Brief cognitive assessment of cancer patients: Evaluation of the Mini-Mental State Examination (MMSE) psychometric properties

Psycho-Oncology

Volumn 16, Issue 4, 2007, Pages 352-357

  Mystakidou, Kyriaki ^a   Tsilika, Eleni ^a   Parpa, Efi ^a   Galanos, Antonis ^a   Vlahos, Lambros ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Advanced cancer; Cognitive function; Reliability; Validity

Indexed keywords

ANTINEOPLASTIC AGENT; OPIATE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; GREECE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MINI MENTAL STATE EXAMINATION; PALLIATIVE THERAPY; PSYCHOMETRY; QUESTIONNAIRE; RATING SCALE; RELIABILITY; STATISTICAL SIGNIFICANCE; TEST RETEST RELIABILITY; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS; NEUROPSYCHOLOGICAL TESTS; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 34247568323     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.1090     Document Type: Article

References (33)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn). American Psychiatric Association: Washington, DC, 1994.
2. Lipowski ZJ. Delirium (acute confusional states). J Am Med Assoc 1987;285:1789-1792.
3. Heflin LH, Meyerowitz BE, Hall P et al. Cancer as a risk factor for long-term cognitive deficits and dementia. J Nat Cancer Inst 2005;97(11):854-856.
4. Tchen N, Juffs HG, Downie FP et al. Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol 2003;21:4175-4183.
5. Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA. "Chemobrain" in breast carcinoma? A prologue. Cancer 2004;101:466-475.
6. Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA. The cognitive sequelae of standard dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer 2004;100:2292-2299.
7. Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12: 189-198.
8. Ylikoski R, Erkinjuntti T, Sulkava R, Juva K, Tilvis R, Valvanne J. Correction for age, education and other demographic variables in the use of the Mini Mental State Examination in Finland. Acta Neurol Scand 1992;85:391-396.
9. Law S, Wolfson C. Validation of a French version of an informant-based questionnaire as a screening test for Alzheimer's disease. Br J Psychiatry 1995;19:422-428.
10. Monsch AU, Foldi NS, Ermini-Funfschilling DE et al. Improving the diagnostic accuracy of the Mini-Mental State Examination. Acta Neurol Scand 1995;92:145-150.
11. Ishizaki J, Meguro K, Ambo H et al. A normative, community-based study of Mini-Mental State in elderly adults: the effect of age and educational level. J Gerontol B 1998;53:359-363.
12. Espino DV, Lichtenstein MJ, Palmer RF, Hazuda HP. Ethnic differences in mini-mental state examination (MMSE) scores: where you live makes a difference. J Am Geriatr Soc 2001;49:538-548.
13. Stewart R, Johnson J, Richards M, Brayne C, Mann A. Medical Council Cognitive Function and Ageing Study. The distribution of Mini-Mental State Examination scores in an older UK African-Caribbean population compared to MRFC CFA study norms. Int J Geriatr Psychiatry 2002; 17:745-751.
14. Hodkinson HM. Evaluation of mental state score for assessment of mental impairment in the elderly. Age Ageing 1972;1:233-238.
15. Wilson LA, Brass W. Brief assessment of the mental state in geriatric domiciliary practice. The usefulness of the Mental Status Questionnaire. Age Ageing 1973;2: 92-101.
16. Sampson EL, Ritchie CW, Lai R, Raven PW, Blanchard MR. A systematic review of the scientific evidence for the efficacy of a palliative care approach in advanced dementia. Int Psychogeriatr 2005; 17(1): 31040.
17. Fountoulakis K, Tsolaki M, Chantzi H, Kazis A. Mini-Mental State Examination (MMSE): a validation study in Greece. Am J Alzheimer's Dis 2000;15:342-345.
18. Oken MM, Creech RH, Tormey DC et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-655.
19. Fountoulakis C, Tsolaki M, Chantzi H, Kazis A. Mini-Mental State Examination (MMSE): a validation study in demented patients from the elderly Greek population (abstract in English). Encephalos 1994; 31:93-102.
20. Aaronson N, Ahmedzai S, Bergman B et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85(5):365-375.
21. Skarstein J, Aass N, Fossa S, Skovlund E, Dahl AA. Anxiety and depression in cancer patients: relation between the Hospital Anxiety and Depression Scale and the European Organization for Research and Treatment of Cancer core quality of life questionnaire. Journal of Psychosom Res 2004;49:27-34.
22. Mystakidou K, Tsilika E, Parpa E, Kalaidopoulou O, Smyrniotis V, Vlahos L. The EORTC Core Quality of Life Questionnaire (QLQ-C30) in terminally ill cancer patients under palliative care: validity and reliability in a Hellenic sample. Int J Cancer 2001;94:135-139.
23. Fayers PM, Aaronson NK, Bjordal K, Sullivan M. EORTC Scoring Manual (3rd edn). EORTC Quality of Life Group: Brussels, 2001.
24. Cronbach LJ. Coefficient alpha and the internal structure of test. Psychometrica 1951;16:297-334.
25. Nunnally J, Bernstein I. Psychometric Theory. McGraw-Hill: New York, 1994.
26. Pereira J, Hanson J, Bruera E. The frequency and clinical course of cognitive impairment in patients with terminal cancer. Cancer 1997;79(4):835-842.
27. Dufouil C, Alperovitch A, Tzourio C. Influence of education on the relationship between white matter lesions and cognition. Neurology 2003;60(5): 831-836.
28. Aanstey KJ, Hofer SM, Luszcz MA. A latent growth curve analysis of late-life sensory and cognitive function over 8 years: evidence for specific and common factors underlying change. Psychol Aging 2003;18(4): 714-726.
29. Ahles TA, Saykin AJ, Furstenberg CT et al. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 2002;20:485-493.
30. Keating NL, Norredam M, Landrum MB, Huskamp HA, Meara E. Physical and mental health status of older long-term cancer survivors. J Am Geriatr Soc 2005;53:2145-2152.
31. Peterson K, DeAngelis L. Weighting the benefits and risks of radiation therapy for low-grade glioma. Neurology 2001;56:1255-1256.
32. Meyers CA, Geara F, Wong P, Morrison WH. Neurocognitive effects of therapeutic irradiation for base of skull tumors. Int J Radiat Oncol Biol Phys 2000;46:51-55.
33. Bruera E, Macmillan K, Hanson J, MacDonald RN. The cognitive effects of the administration of narcotic analgesics in patients with cancer pain. Pain 1989;39: 13-16.